Document Type
Blog Post
Publication Date
4-28-2021
Disciplines
Nervous System Diseases
Digital USD Citation
Serbin, Kenneth P., "Roche confirms tominersen as ineffective, while Triplet provides key details for trial of drug to slow major driver of Huntington's disease" (2021). At Risk for Huntington's Disease. 304.
https://digital.sandiego.edu/huntingtons/304
